Efficacy analysis of CAPOX regimen and SOX regimen in the treatment of advanced gastric cancer
10.3969/j.issn.1009-9905.2017.11.010
- VernacularTitle:CAPOX方案和SOX方案治疗进展期胃癌效果分析
- Author:
Xiao-Mei LIU
1
;
Xiao-Hua WANG
;
Qiang ZHOU
;
Zhong-Yin LUO
;
Gao-Xiang PU
;
Wen-Jun LUO
Author Information
1. 四川省遂宁市中心医院 肿瘤中心
- Keywords:
Advanced gastric cancer;
CAPOX regimen;
SOX regimen;
Therapeutic effect
- From:
Chinese Journal of Current Advances in General Surgery
2017;20(11):872-875
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To study the effect of CAPOX regimen and SOX regimen in the treatment of advanced gastric cancer.Methods:140 patients with advanced gastric cancer who received chemotherapy from January 2010 to June 2011 in the hospital were enrolled in this study.The patients were divided into observation group (CAPOX regimen) 72 cases and control group(SOX regimen) 68 cases according to the different chemotherapy protocols,two groups were treated with central venous catheter,and in the course of chemotherapy for the given antiemetic,hepatoprotective and Acid suppression related drugs.The observation group was treated with CAPOX regimen,and the control group was treated with SOX regimen,and the 21d was used as the 1 chemotherapy cycle,and the effect was evaluated after 2 cycles of chemotherapy.Results:The effective rate of observation group was 33.33％ (24/72),compared with the control group of 33.82％(23/68),the difference was not statistically significant (P＞0.05).The incidence of hand foot syndrome in the observation group was 16.67％ (12/72),was significantly higher than the control group of 2.94％(2/68),the difference was statistically significant(P＜0.05).The total incidence of adverse reactions in the observation group was 58.33％ (42/72),compared with the control group of 57.35％(39/68),the difference was not statistically significant(P＞0.05).The 1 to 5 year survival rate of the observation group compared with the control group was not statistically significant(P＞0.05).The two groups before and after treatment of CD3+,CD3+CD4+ and CD3+/CD8+ compared,the difference was not statistically significant (P＞0.05).Conclusion:Using CAPOX scheme and the SOX regimen can be better in the treatment of advanced gastric cancer,curative effect and short and long term survival rate was almost equal and influence of immune function of patients with no significant difference,but CAPOX scheme may exist higher hand foot syndrome probability,it is worth clinical optic.
